Stem Cell Therapy Market Analysis Report, High Demand, Outlook, Industry Analysis, Forecast Report 2027

Emerging research logo

Stem Cell Therapy Market Size – USD 342.7 million in 2019, Market Growth – CAGR of 36.2%

VANCOUER, BC, CANADA, April 1, 2022 / — The Stem Cell Therapy market report studies many aspects of the industry such as market size, market status, trends market and forecasts. The report also provides brief information about specific competitors and growth opportunities with key market drivers. Find the comprehensive analysis of the Stem Cell Therapy market segmented by companies, region, type and applications in the report.

The global stem cell therapy market is expected to reach USD 3,693.6 million by 2027, according to a new report from Emergen Research. The stem cell therapy market is witnessing an increased demand owing to the increase in the number of clinical trials all over the world. Stem cells are applicable to the development of regenerative medicine, commonly used in the field of dermatology. However, the demand for stem cell applications in the oncology segment will witness the greatest growth owing to several pipeline projects present for the treatment of cancer or tumors.

Allogeneic stem cell therapy led the stem cell therapy segment by type. Allogeneic transplantation is recommended for patients who are at high risk of relapse even after successful treatment with chemotherapy. An increase in the frequency of cancer relapses propelled demand for the segment. The segment has an added advantage as it manufactures its own immune stem cells. These cells have the potential to kill cancer cells that remain after high dose treatment with cytotoxic drugs.

Download Free Sample PDF Copy of Stem Cell Therapy Market @

Main highlights of the report:

Improved state-of-the-art orthopedic treatments involving stem cell therapy have contributed to pain relief and also recovery time. It eliminates the need for medications and invasive surgery, such as joint replacements, which increases mobility. The regenerative medicine segment is expected to grow with a CAGR of 36.4% during the forecast period.
The hospital held a larger market share due to the growing preference for stem cell therapies in these institutions. Hospitals are affiliated with academic institutes and research laboratories for the development of new therapies. Hospitals are implementing the latest findings.
North America will account for the largest share of the global stem cell market. The major contribution will come from the United States, and the region will experience strong growth due to increased funding from private and government companies for clinical trials.

Major participants include DuPont Virgin Health Bank, Celgene Corporation, ReNeuron Group plc, Biovault Family, Precious Cells International Ltd., Mesoblast Ltd., Opexa Therapeutics, Inc., Caladrius, Neuralstem, Inc., and Pluristem, among others.

In addition, this report examines the key drivers influencing market growth, the opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes major emerging trends and their impact on current and future development.

Access Full Summary of this Report @

The report has been assembled based on the synthesis, analysis and interpretation of data accumulated regarding the parent market from various resources. In addition, a study has been carried out on the economic conditions and other economic indicators and factors to assess their respective impact on the Hearing Aids market, along with the present impact, in order to make strategic and informed predictions about the scenarios of the market. This is mainly due to the untapped potentials present in developing countries, in terms of product pricing and revenue generation.

Segments covered in the report:

For the purposes of this report, Emergen Research has segmented the global stem cell therapy market on the basis of type, application, end-user, and region:

Type Outlook (Revenue, USD Million; 2017-2027)
Allogeneic Stem Cell Therapy
Autologous stem cell therapy

Application Outlook (Revenue, USD Million; 2017-2027)
Regenerative medicine
Hematological stem cells
Soft tissue injuries
Cardiovascular and myocardial infarction
Liver disorder
Drug discovery and development

End User Outlook (Revenue, USD Million; 2017-2027)

The full regional analysis covers the following regions:

North America (United States, Canada, Mexico)

Europe (UK, Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa, Rest of MEA)

Buy now:

Answers to key questions in the report:

Who are the top five players in the Stem Cell Therapy market?
How will the stem cell therapy market change over the next five years?
Which product and application will occupy the lion’s share of the Stem Cell Therapy market?
What are the drivers and restraints of Stem Cell Therapy Market?
Which regional market will show the strongest growth?
What will be the CAGR and size of the Stem Cell Therapy market throughout the forecast period?

Explore More Emergen @ Research Reports

Rehabilitation Robotics Market

Alopecia Market

Brachytherapy Market @

Depression Treatment Market @

Electrosurgical Devices Market @

About Us :

Emergen Research is a market research and consulting firm that provides syndicated research reports, custom research reports, and consulting services. Our solutions are uniquely focused on your goal of locating, targeting and analyzing changes in consumer behavior across demographics, across industries, and helping customers make smarter business decisions. We offer market intelligence research ensuring relevant and factual research across multiple sectors including health, touchpoints, chemicals, types and energy.

Eric Lee
Emerging research
+91 90210 91709
[email protected]
Visit us on social media: